GVOKE VIALDX
Live / Applied — Second extension granted (statement of use) (as of 05 Aug 2025)
What this means for you
Not registered yet, but its 01 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98161602
- Mark type
- Stylized text
- Filed
- 01 Sept 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use
- Class 044 — Medical, beauty and agricultural services: Providing information relating to diagnostic properties of pharmaceuticals
Owner
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
Prior registrations
Prosecution history
- 14 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 14 Jan 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2025 — SOU EXTENSION 2 GRANTED
- 05 Aug 2025 — SOU EXTENSION 2 FILED
- 05 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2025 — SOU EXTENSION 1 GRANTED
- 03 Feb 2025 — SOU EXTENSION 1 FILED
- 03 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jun 2024 — PUBLISHED FOR OPPOSITION
- 22 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED